CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 467062-467243 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"At last visit, FEV 1 improved from baseline by 260 mL (11%), 320 mL (13%), and 400 mL (16%) in patients treated with roflumilast 100 μg, 250 μg, and 500 μg once daily, respectively.","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T54482","span":{"begin":0,"end":181},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T54482","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T167","span":{"begin":0,"end":181},"obj":"Sentence"}],"attributes":[{"subj":"T167","pred":"source","obj":"CORD-19_Custom_license_subset"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#93c1ec","default":true},{"id":"CORD-19_Custom_license_subset","color":"#dcec93"}]}]}}